| Schedule of Impact of Stock-Based Compensation in Consolidation and Combined Statements of Income |
Stock-based compensation expense and the associated tax benefits impacting our Condensed Consolidated Statements of Income were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | (In thousands) | | October 2, 2020 | | September 27, 2019 | | October 2, 2020 | | September 27, 2019 | | Compensation costs for equity-based awards | | $ | 1,284 | | | $ | 1,124 | | | $ | 4,286 | | | $ | 3,339 | | | Compensation costs for liability-based awards | | (196) | | | 798 | | | 2,213 | | | 2,613 | | | Total compensation costs, pre-tax | | $ | 1,088 | | | $ | 1,922 | | | $ | 6,499 | | | $ | 5,952 | | | Future tax benefit | | $ | 235 | | | $ | 416 | | | $ | 1,404 | | | $ | 1,288 | |
|
| Schedule of Non-Qualified Stock Options, Activity |
The following table provides a summary of the activities for NQOs and RSUs for the nine months ended October 2, 2020: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | NQOs | | RSUs | | (In thousands, except per share data) | | Shares | | Weighted Average Exercise Price Per Share | | Shares | | Weighted Average Grant Date Fair Value Per Share | | Outstanding at January 1, 2020 | | 77 | | | $ | 23.30 | | | 301 | | | $ | 30.30 | | | Granted | | — | | | $ | — | | | 129 | | | $ | 51.98 | | | Exercised | | (3) | | | $ | 21.43 | | | — | | | $ | — | | | Vested | | — | | | $ | — | | | (147) | | | $ | 30.55 | | | Issued in exchange | | — | | | $ | — | | | 16 | | | $ | 52.28 | | | Cancelled in exchange | | — | | | $ | — | | | (16) | | | $ | 29.00 | | | Forfeited or expired | | — | | | $ | — | | | (18) | | | $ | 40.67 | | | Outstanding at October 2, 2020 | | 74 | | | $ | 23.37 | | | 265 | | | $ | 41.41 | |
|